Evidence method
Level · gp.fundamentals.debt_to_revenue
186.67% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BMRN · Mar 31, 2026
BIOMARIN PHARMACEUTICAL INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001048477-26-000008General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.73% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.80% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
2.83% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
166.17% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
74.55% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
16.92% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
23.34% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5.67% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History9 statesHistory building
Period transition
What moved in the state?
- Previous
- 3.20%
- Current
- 2.73%
- Delta
- -0.47%
- Previous
- 25.70%
- Current
- 28.80%
- Delta
- 3.09%
- Previous
- 12.87%
- Current
- 2.83%
- Delta
- -10.04%
- Previous
- 40.32%
- Current
- 166.17%
- Delta
- 125.85%
- Previous
- 77.73%
- Current
- 74.55%
- Delta
- -3.18%
- Previous
- 12.71%
- Current
- 16.92%
- Delta
- 4.21%
- Previous
- 28.62%
- Current
- 23.34%
- Delta
- -5.29%
- Previous
- 5.63%
- Current
- 5.67%
- Delta
- 0.04%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · BMRN Fundamental State →Has State · BIOMARIN PHARMACEUTICAL INC →Transitioned To · BMRN R_AND_D_INTENSITY_DECREASED →Transitioned To · BMRN SBC_INTENSITY_INCREASED →Transitioned To · BMRN Fundamental State →Transitioned To · BMRN CAPEX_INTENSITY_DECREASED →Transitioned To · BMRN CASH_GENERATION_INCREASED →Transitioned To · BMRN GROWTH_DECREASED →Transitioned To · BMRN INVENTORY_PRESSURE_INCREASED →Transitioned To · BMRN MARGIN_DECREASED →Transitioned To · BMRN PROFITABILITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.